Amyris, Inc. AMRS
0.05 +0.05
Quote time unavailable
Day range unavailable
52-week range unavailable
- Analysts
- Hold
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Financials — quick view
AMRS Revenue — quarterly 56.08M
AMRS Net income — quarterly -193.34M
AMRS EPS — quarterly -0.53
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 22, 2023 | Jun 1, 2023 | 0.23 | — | — | — |
| May 9, 2023 | Mar 1, 2023 | -0.34 | — | — | — |
| Mar 15, 2023 | Dec 1, 2022 | -0.20 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | -0.21 | — | — | — |
| Aug 9, 2022 | Jun 1, 2022 | -0.28 | — | — | — |
| May 10, 2022 | Mar 1, 2022 | -0.24 | — | — | — |
News
Amyris and Ingredion Wind Down RealSweet Joint Venture 
Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line 
Squalene Market to Grow by USD 62.9 Million from 2024-2028, Driven by Rising Adoption of UVA/UVB Filters in Sunscreens, Report Powered by AI - Technavio 
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session 
Retail investors flock to penny stocks WeWork, Amyris, Proterra 
AMRS Stock Surges 152% as Amyris Files for Bankruptcy 
Biotech Company Amyris Files for Bankruptcy 
Why Is Amyris (AMRS) Stock Down 67% Today? 
AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION 
Stocks That Hit 52-Week Lows On Wednesday
Your note
Sign in to keep a note on AMRS — it syncs with the Stock Master app.